On the public citation graph
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
0 signed · 108 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cpt.1391openalex-snapshot
Polymorphic Variants in NR 1I3 and UGT 2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study
inferredcites →https://doi.org/10.1007/s00251-017-1007-5openalex-snapshot
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions
inferredcites →https://doi.org/10.1016/j.clinbiochem.2016.07.014openalex-snapshot
Evaluation of the iPLEX® ADME PGx Pro Panel and allele frequencies of pharmacogenetic markers in Danes
inferredcites →https://doi.org/10.1016/j.conctc.2019.100493openalex-snapshot
Biomarker-guided trials: Challenges in practice
inferredcites →https://doi.org/10.1038/gim.2017.247openalex-snapshot
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
inferredcites →https://doi.org/10.1038/ng1001-233openalex-snapshot
Haplotype tagging for the identification of common disease genes
inferredcites →https://doi.org/10.1038/s41571-019-0179-3openalex-snapshot
Therapeutic implications of germline genetic findings in cancer
inferredcites →https://doi.org/10.1080/14737159.2018.1461561openalex-snapshot
Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine
inferredcites →https://doi.org/10.1093/jnci/djm022openalex-snapshot
Biomarker-Adaptive Threshold Design: A Procedure for Evaluating Treatment With Possible Biomarker-Defined Subset Effect
inferredcites →https://doi.org/10.1093/nar/gky1120openalex-snapshot
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019
inferredcites →https://doi.org/10.1146/annurev-genom-083117-021602openalex-snapshot
Genotype Imputation from Large Reference Panels
inferredcites →https://doi.org/10.1186/1757-2215-2-14openalex-snapshot
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
inferredcites →https://doi.org/10.1186/s40246-018-0157-3openalex-snapshot
Integrating rare genetic variants into pharmacogenetic drug response predictions
inferredcites →https://doi.org/10.1208/s12248-017-0161-xopenalex-snapshot
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
inferredcites →https://doi.org/10.1258/cvd.2012.012001openalex-snapshot
Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues
inferredcites →https://doi.org/10.1371/journal.pone.0100487openalex-snapshot
Association between CYP1A2 and CYP1B1 Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
inferredcites →https://doi.org/10.18632/oncotarget.13135openalex-snapshot
Genetic variants associated with gastrointestinal symptoms in Fabry disease
inferredcites →https://doi.org/10.18632/oncotarget.22505openalex-snapshot
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy
inferredcites →https://doi.org/10.20517/2394-4722.2018.04openalex-snapshot
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives
inferredcites →https://doi.org/10.3389/fphar.2018.00350openalex-snapshot
Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study
inferredcites →https://doi.org/10.3390/ht7040033openalex-snapshot
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology
inferredcites →https://doi.org/10.3390/ht7040040openalex-snapshot
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives
inferredcites →https://doi.org/10.3390/ht9020008openalex-snapshot
DMETTM Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4781566openalex-extracted
DTC Pharmacogenetic Testing and Health Insurance: Good for Health, Good for Business?
inferred← citeshttps://doi.org/10.1002/ardp.202300134openalex-snapshot
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening
inferred← citeshttps://doi.org/10.1007/978-1-0716-1839-4_15openalex-snapshot
Integration of DNA Microarray with Clinical and Genomic Data
inferred← citeshttps://doi.org/10.1007/978-1-0716-1839-4_17openalex-snapshot
Microarray Data Analysis Protocol
inferred← citeshttps://doi.org/10.1007/978-3-030-51519-5_69-1openalex-snapshot
Personalized Medicine and Drug Metabolism
inferred← citeshttps://doi.org/10.1007/978-3-030-84860-6_69openalex-snapshot
Personalized Medicine and Drug Metabolism
inferred← citeshttps://doi.org/10.1007/978-3-030-91415-8_6openalex-snapshot
Identification of Protein Markers Predictive of Drug-Specific Survival Outcome in Cancers
inferred← citeshttps://doi.org/10.1007/s00280-023-04638-0openalex-snapshot
The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations
inferred← citeshttps://doi.org/10.1007/s10787-026-02128-2openalex-snapshot
Drug-disease interactions in inflammation: mechanisms, clinical Impact, and future directions
inferred← citeshttps://doi.org/10.1007/s13721-025-00644-9openalex-snapshot
In-silico analysis of structural and functional impact of missense SNPs of human CTSD protein on cancers and identification of potential novel cancer SNP biomarkers
inferred← citeshttps://doi.org/10.1007/s40203-023-00154-4openalex-snapshot
In-silico mining to glean SNPs of pharmaco-clinical importance: an investigation with reference to the Indian populated SNPs
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00013-xopenalex-snapshot
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00139-0openalex-snapshot
Ethical Perspectives on Pharmacogenomic Profiling
inferred← citeshttps://doi.org/10.1016/b978-0-12-822703-9.00002-8openalex-snapshot
What is precision medicine in oncology?
inferred← citeshttps://doi.org/10.1016/b978-0-323-95502-7.00086-5openalex-snapshot
Biological Pathways
inferred← citeshttps://doi.org/10.1016/b978-0-323-95502-7.00145-7openalex-snapshot
Preclinical: Drug Target Identification and Validation in Humans
inferred← citeshttps://doi.org/10.1016/b978-0-443-18649-3.00018-5openalex-snapshot
Drug hypersensitivity linked to genetic variations of human leukocyte antigen
inferred← citeshttps://doi.org/10.1016/b978-0-443-29279-8.00003-xopenalex-snapshot
Tools and technologies for biomarker discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-34671-2.00023-2openalex-snapshot
Pharmacogenomics-based nanoprecision medicine
inferred← citeshttps://doi.org/10.1016/j.biochi.2025.07.027openalex-snapshot
Codon usage and antibiotic resistance: A hidden evolutionary mechanism
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.112952openalex-snapshot
Mendelian randomization in pharmacogenomics: The unforeseen potentials
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116478openalex-snapshot
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience
inferred← citeshttps://doi.org/10.1016/j.cotox.2026.100622openalex-snapshot
Pharmacogenomics and toxicogenomics of osteoporosis therapy: Genetic determinants of drug efficacy and skeletal adverse effects
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.04.015openalex-snapshot
Towards population-specific pharmacogenomics in the era of next-generation sequencing
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e18696openalex-snapshot
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1016/s0168-8278(23)01363-6openalex-snapshot
Genetic biomarkers for sorafenib response in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-022-24246-xopenalex-snapshot
Integrative network analysis interweaves the missing links in cardiomyopathy diseasome
inferred← citeshttps://doi.org/10.1039/d6bm00535gopenalex-snapshot
Tailored injectable nanocomposite hydrogels for high-performance biomedical applications
inferred← citeshttps://doi.org/10.1080/1062936x.2026.2667960openalex-snapshot
Integrating machine learning and pharmacogenomics for biomarker discovery, identification and prioritization of potential drug candidates in ovarian cancer
inferred← citeshttps://doi.org/10.1080/14622416.2025.2452834openalex-snapshot
Pharmacogenomic curriculum in Australian medical schools: a content analysis study
inferred← citeshttps://doi.org/10.1080/17512433.2023.2293999openalex-snapshot
Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges
inferred← citeshttps://doi.org/10.1093/jpp/rgag001openalex-snapshot
Precision pharmaceutics: bioinformatics and pharmacogenomics as catalysts for personalized drug therapy
inferred← citeshttps://doi.org/10.1101/2021.02.26.433014openalex-snapshot
Integrative network analysis interweaves the missing links in cardiomyopathy diseasome
inferred← citeshttps://doi.org/10.1111/bcpt.13654openalex-snapshot
Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies
inferred← citeshttps://doi.org/10.1111/cts.70442openalex-snapshot
Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice
inferred← citeshttps://doi.org/10.1124/pharmrev.123.000750openalex-snapshot
Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test
inferred← citeshttps://doi.org/10.1128/msphere.00944-24openalex-snapshot
Advances in cytokine gene polymorphisms in tuberculosis
inferred← citeshttps://doi.org/10.1155/humu/9614566openalex-snapshot
Development of a New Portable Genetic Analyzer for Point‐of‐Care Molecular Genetics and Pharmacogenomics Analysis
inferred← citeshttps://doi.org/10.1177/0976500x251321885openalex-snapshot
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
inferred← citeshttps://doi.org/10.1177/20406223211063024openalex-snapshot
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report
inferred← citeshttps://doi.org/10.1186/s12967-022-03705-zopenalex-snapshot
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
inferred← citeshttps://doi.org/10.1186/s12967-023-04101-xopenalex-snapshot
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
inferred← citeshttps://doi.org/10.1186/s40246-023-00508-1openalex-snapshot
Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1771105/v1openalex-snapshot
Integrative network analysis interweaves the missing links in cardiomyopathy diseasome
inferred← citeshttps://doi.org/10.2147/pgpm.s327313openalex-snapshot
Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China
inferred← citeshttps://doi.org/10.2147/pgpm.s490135openalex-snapshot
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
inferred← citeshttps://doi.org/10.2174/0118756921420307251127050717openalex-snapshot
Advanced Cancer Drug Development through Reverse Pharmacology: Integrating Traditional Knowledge and Herbal Therapies
inferred← citeshttps://doi.org/10.2217/pgs-2023-0091openalex-snapshot
Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism
inferred← citeshttps://doi.org/10.2217/pgs-2023-0243openalex-snapshot
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities
inferred← citeshttps://doi.org/10.3389/978-2-8325-2184-7openalex-snapshot
Adoption of Artificial Intelligence in Human and Clinical Genomics
inferred← citeshttps://doi.org/10.3389/fgene.2023.1261876openalex-snapshot
Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
inferred← citeshttps://doi.org/10.3389/fmolb.2022.907150openalex-snapshot
A comprehensive survey on computational learning methods for analysis of gene expression data
inferred← citeshttps://doi.org/10.3389/fonc.2023.1145986openalex-snapshot
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity
inferred← citeshttps://doi.org/10.3389/fphar.2021.833000openalex-snapshot
Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
inferred← citeshttps://doi.org/10.3389/fphar.2022.931531openalex-snapshot
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
inferred← citeshttps://doi.org/10.3389/fphar.2023.1008330openalex-snapshot
PAnno: A pharmacogenomics annotation tool for clinical genomic testing
inferred← citeshttps://doi.org/10.3389/fphar.2023.1260276openalex-snapshot
Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges
inferred← citeshttps://doi.org/10.3389/fphar.2024.1494482openalex-snapshot
Allele and genotype frequencies of variants in P450 cytochromes, transports, and DNA repair enzymes in the Dominican Republic population
inferred← citeshttps://doi.org/10.3389/fphar.2025.1548991openalex-snapshot
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis
inferred← citeshttps://doi.org/10.3389/fphar.2026.1842379openalex-snapshot
Why pharmacogenomic biomarkers for chemotherapy-induced peripheral neuropathy fail: a systematic review of genetic associations, replication, and clinical translation
inferred← citeshttps://doi.org/10.3390/biomedicines10051210openalex-snapshot
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics
inferred← citeshttps://doi.org/10.3390/biomedicines12071384openalex-snapshot
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
inferred← citeshttps://doi.org/10.3390/bios10120202openalex-snapshot
Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents
inferred← citeshttps://doi.org/10.3390/cancers13061392openalex-snapshot
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer’s Achilles’ Heel
inferred← citeshttps://doi.org/10.3390/cancers13071566openalex-snapshot
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation
inferred← citeshttps://doi.org/10.3390/cancers15061647openalex-snapshot
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
inferred← citeshttps://doi.org/10.3390/cells11020189openalex-snapshot
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
inferred← citeshttps://doi.org/10.3390/genes15010087openalex-snapshot
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future
inferred← citeshttps://doi.org/10.3390/ijms25042197openalex-snapshot
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/jpm12081303openalex-snapshot
Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
inferred← citeshttps://doi.org/10.3390/ph14111077openalex-snapshot
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
inferred← citeshttps://doi.org/10.4018/979-8-3693-6597-7.ch009openalex-snapshot
Trends of Pharmacogenomics in Personalized Medicine
inferred← citeshttps://doi.org/10.47820/recima21.v3i7.1652openalex-snapshot
FUNDAMENTOS E APLICAÇÕES DA FARMACOGENÔMICA NO TRATAMENTO DE DOENÇAS.
inferred← citeshttps://doi.org/10.51847/cpavouwbc4openalex-snapshot
Pharmacogenomics and Precision Medicine in Psychiatry : A Comprehensive Review
inferred← citeshttps://doi.org/10.6084/m9.figshare.21384308openalex-snapshot
Additional file 1 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
inferred← citeshttps://doi.org/10.6084/m9.figshare.21384311openalex-snapshot
Additional file 2 of Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
inferred← citeshttps://doi.org/10.6084/m9.figshare.26587080openalex-snapshot
Additional file 1 of A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26587083openalex-snapshot
Additional file 2 of A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26587086openalex-snapshot
Additional file 3 of A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26587089openalex-snapshot
Additional file 4 of A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26604133openalex-snapshot
Additional file 1 of Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
inferred← citeshttps://doi.org/10.6084/m9.figshare.26604136openalex-snapshot
Additional file 2 of Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
inferred← citeshttps://doi.org/10.6084/m9.figshare.26604139openalex-snapshot
Additional file 3 of Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.